Perceptive Advisors’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$130M Sell
1,540,384
-790,267
-34% -$57.4M 2.53% 11
2025
Q4
$176M Buy
2,330,651
+978,662
+72% +$61.6M 3.14% 5
2025
Q3
$53.7M Buy
1,351,989
+169,841
+14% +$6.48M 1.55% 23
2025
Q2
$51.3M Buy
1,182,148
+59,381
+5% +$2.26M 1.9% 12
2025
Q1
$41.9M Buy
1,122,767
+75,535
+7% +$2.92M 1.48% 19
2024
Q4
$47.4M Sell
1,047,232
-967,775
-48% -$49.4M 1.31% 24
2024
Q3
$118M Sell
2,015,007
-90,629
-4% -$4.34M 2.5% 10
2024
Q2
$82.9M Buy
2,105,636
+45,241
+2% +$2.2M 2% 12
2024
Q1
$137M Buy
2,060,395
+232,494
+13% +$10.2M 2.4% 9
2023
Q4
$51.1M Hold
1,827,901
1.14% 28
2023
Q3
$38.9M Buy
+1,827,901
New +$40.3M 1.3% 24

Other funds holding APGE